
from youarewithinthenorms.com
NORMAN J CLEMENT RPH., DDS, NORMAN L. CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., INC., SPIRIT OF REV. IN THE SPIRIT OF WALTER R. CLEMENT BS., MS, MBA. HARVEY JENKINS, MD, PH.D., IN THE SPIRIT OF C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., M.B.A., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., EVELYN J. CLEMENT, IN THE SPIRIT OF WALTER F. WRENN III., MD., JULIE KILLINGSWORTH, RENEE BLARE, RPH, DR. TERENCE SASAKI, MD LESLY POMPY MD., CHRISTOPHER RUSSO, MD., NANCY SEEFELDT, IN THE SPIRIT OF WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ARNAND, MD., IN THE SPIRIT OF RICHARD KAUL, MD., IN THE SPIRIT OF LEROY BAYLOR, JAY K. JOSHI MD., MBA, AISHA GARDNER, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS
Challenging the DEA: Medical Jurisprudence and the Rule of Law

“..AS THE FIFTH CIRCUIT COURT PUTS THE DEA BACK IN ITS PLACE..”
JURISDICTIONAL BOUNDARIES: A Legal Brief Against the DEA’s Encroachment into Medical Practice

From A Respected Former Member of the State of Florida Board of Pharmacy writes;
“The Board of Medicine in Florida has rules that allow it to sanction a medical doctor who provides fraudulent, misleading, or otherwise improper testimony against another physician. I have tried multiple times to get the Board of Pharmacy to issue the same rule for pharmacies, but the state lawyers say the Board of Pharmacy lacks statutory authority to do so. I argued that if the Board of Medicine had statutory authority, then the Florida Board of Pharmacy should have the same authority. The state’s lawyers don’t have the balls (HEUVOS) to take on the DEA!!”

This article from youarewithinthenorms highlights a legal and medical dispute involving healthcare providers who argue that the DEA has overstepped its authority by criminalizing legitimate medical practices. Through court filings and personal testimonies, the text asserts that federal agencies use subjective data analytics and “red flags” to target pharmacists and doctors without proving actual criminal intent.
The article and these authors maintain that law enforcement lacks the scientific expertise necessary to dictate standards of care or define what constitutes a valid medical purpose for pain management.
Most importantly, numerous articles published on youarewithinthenorm.com document and cite Supreme Court precedents to argue that the government must prove that practitioners knowingly acted outside professional norms, rather than merely relying on prescription statistics.

THE D.E.A. DIVERSION FROM THE TRUTH
CLICK BELOW
Introduction: The Erosion of the Rule of Law in Controlled Substance Oversight
The Rule of Law serves as the bedrock of the American legal system, a structural safeguard that ensures government power is exercised only within the bounds of clear statutory authority. When a federal agency begins to manufacture its own extra-legal standards and “own science” through administrative creep, it threatens the fundamental separation of powers between law enforcement and the practice of medicine.

This systematic erosion is nowhere more apparent than in the recent conduct of the Drug Enforcement Administration (DEA), which has increasingly utilized mechanisms like Auer deference to circumvent legislative intent and seize property without adequate judicial oversight.
The thesis of this brief is clear: The DEA has transformed into a rogue sub-agency, operating as an unauthorized federal medical board in open defiance of the Controlled Substances Act (SCA). By ignoring the specific jurisdictional boundaries established by Congress, the DEA has moved beyond its role as a regulator of drug flow to become an arbiter of clinical practice.

This document outlines the legal and statutory framework that renders the DEA’s current enforcement tactics—specifically its use of algorithmic persecution and subjective standards—a violation of federal law. The transition from philosophical overreach to specific illegality begins with the statutory limitations Congress explicitly placed upon the Attorney General’s authority.

MEET DR. DONALD L. SULLIVAN, PROFESSOR, THE OHIO STATE COLLEGE OF PHARMACY, LICENSED IN BOTH FLORIDA AND OHIO
A Statutory Authority and the Mandatory Role of Health Agencies
The legislative intent behind the Controlled Substances Act (CSA) is predicated on a single, vital distinction: medical expertise, not law enforcement intuition, must serve as the gatekeeper of drug scheduling and medical legitimacy.
Congress recognized that federal agents are inherently “unqualified” to evaluate the clinical complexities of patient care. Consequently, the CSA establishes a closed regulatory system where law enforcement’s authority is strictly subordinate to the scientific and medical evaluations of specialized health agencies.

Under 21 U.S.C. § 811(b), the Attorney General is legally required to request a “scientific and medical evaluation” from the Secretary of Health and Human Services (HHS) before initiating drug scheduling.
The statute is unambiguous: the Secretary’s recommendations are binding on the Attorney General regarding scientific and medical matters. This requirement ensures that law enforcement cannot unilaterally declare a substance’s medical utility—or lack thereof—based on enforcement priorities.
Furthermore, 21 U.S.C. § 801(1) reinforces that law enforcement agencies lack the standing to determine whether a drug has a “useful and legitimate medical purpose” or is “necessary to maintain the health and general welfare of the American people.”
These statutes create the following absolute Jurisdictional Bars, prohibiting the DEA from independently:
1.Defining what constitutes a “legitimate medical purpose” for a specific prescription.
2.Determining the “usual course of professional practice” for any medical specialty.
3.Establishing the medical necessity of controlled substances for specific patient populations.
4.Setting quantitative dosage standards or mandatory Morphine Milligram Equivalent (MME) maximums.
5.Evaluating the clinical risks of FDA-approved medications versus illicit street drugs.
The DEA’s institutional awareness of these limitations is not merely a matter of legal theory; it is a matter of formal, written record.

Anand-Borel-Clement (ABC) Pharmacological Trinity Concept: While opioids target G-protein-coupled receptors to block pain signals, benzodiazepines enhance GABAergic inhibition to provide necessary sedation and muscle relaxation. This synergistic approach allows for lower medication doses, which effectively reduces adverse side effects while extending the duration of relief. Beyond clinical mechanics, the text uses a theological metaphor of the Holy Trinity to illustrate how these distinct agents work in dynamic communion to heal the patient. Ultimately, the goal of this integrated therapy is to restore the individual’s quality of life, enabling them to return to employment, mobility, and social connection.
The Prevoznik Admissions: Institutional Acknowledgement of Jurisdictional Limits
The strategic value of correspondence from Deputy Assistant Administrator Thomas W. Prevoznik (dated 2019 and 2021) cannot be overstated. These letters constitute formal admissions that the DEA’s current enforcement tactics frequently cross the very boundaries the agency admits it cannot legally inhabit.

The DEA is not a State Medical Board
The DEA has explicitly admitted that it does not act as the federal equivalent of a state medical board. As stated by Prevoznik in 2021, the agency lacks the authority to oversee the general practice of medicine or to issue guidelines that constitute clinical advice. The agency’s role is to regulate the flow of controlled substances, not to dictate the parameters of patient-provider interactions.


Absence of Dosage Standards
Crucially, the DEA has admitted that federal law and DEA regulations do not impose specific quantitative maximums or minimums on the amount of medication that can be prescribed. This includes a formal acknowledgment that there are no federally mandated MME limits (such as a 90 MME cap) for prescriptions, despite the agency’s frequent use of such numbers to justify investigations.

Deference to Professional Judgment
In the 2019 Prevoznik correspondence, the DEA emphasized its support for the “prescriptive authority of an individual practitioner” to treat pain within acceptable medical standards. The agency stated that practitioners are authorized to treat patients according to their professional medical judgment.
However, a profound chasm exists between these official policy admissions and the agency’s actual enforcement tactics, which have increasingly sought to criminalize medical judgment by ignoring the high evidentiary bar set by the Supreme Court.

The Ruan Standard: From Negligence to Subjective Scienter
The Supreme Court’s unanimous 9-0 ruling in Ruan v. United States represents a paradigm shift that fundamentally dismantled the DEA’s use of “negligence” as a standard for prosecution. The Court established that the government must prove more than a mere deviation from medical norms to convict a registered practitioner; it must prove criminal intent.

Under § 841(a)(1) and § 1306.04(a), the government is now mandated to meet a two-pronged requirement:
A.Subjective Scienter: The defendant subjectively knew that the prescription was not for a legitimate medical purpose.
B.Objective Standard: The prescription was objectively issued outside the usual course of professional practice.

The Ruan standard clarifies that the government cannot criminalize “good faith medical mistakes.” By requiring proof of the practitioner’s actual mental state (mens rea), the Court effectively invalidated the DEA’s historical reliance on “pill numbers” and volume metrics as proxies for guilt. In a desperate attempt to circumvent this high evidentiary bar, the DEA has doubled down on data analytics—essentially attempting to smuggle a “negligence” standard back into the courtroom by framing a physician’s failure to observe arbitrary “red flags” as evidence of criminal knowledge.

Algorithmic Persecution: Data Analytics as “Junk Science”
Following Ruan, the DEA has shifted toward a “Minority Report” style of policing, using data analytics to create “scapegoats” for the opioid crisis. These algorithms treat clinical practice as a mathematical anomaly, utilizing what can only be described as “junk science”—data metrics entirely divorced from clinical investigation, patient testimony, or medical record review.
Recent FOIA discoveries reveal the absurdity of the metrics used to assign “risk scores” to physicians. These “red flags” often include factors that are not clinically relevant to diversion, such as how many cars a physician owns, the proximity of their home to water, or the wealth of their neighbors. By assigning numerical scores to these irrelevant factors, the DEA targets practitioners not based on evidence of a crime, but on algorithmic profiles that frequently “cherry-pick” foreign medical graduates and physicians of color for investigation.
| Indicator (“Red Flag”) | Clinical Reality / FOIA Discovery |
| High MME / Pill Volume | Specialized pain or palliative care for complex cases; high volume does not equal diversion. |
| Distance Traveled | Often a result of the DEA “terrorizing” local providers, forcing patients to seek care elsewhere. |
| Opioid-to-Non-Opioid Ratio | A metric that discriminates against pain specialists while ignoring clinical necessity. |
| Demographics & Status | FOIA records show analytics track race, foreign graduate status, car ownership, and proximity to water. |
| Economic Metrics | “Numerical scores” assigned based on the wealth of neighbors or percentage of brand-name medicine. |
This reliance on algorithms is a form of “junk science” that replaces the Rule of Law with a system of discriminatory profiling. It ignores the fundamental truth that every valid prescription is based on an individual clinical determination, not a mathematical ratio.

Case Studies in Enforcement Overreach: Pronto, Suntree, and Miami-Luken
The DEA’s systematic use of “procedural end-runs” to bypass court orders and statutory limits is evidenced by its conduct in several landmark cases.
- Pronto Pharmacy LLC (Norman Clement): In this case, the DEA utilized subjective standards—including Google Maps to measure patient travel distance—as a substitute for actual evidence of diversion. Despite no proof that any medication was diverted, the DEA pursued revocation based on the “red flag” testimony of Dr. Donald Sullivan, a consultant who identified “illegitimacy” without conducting a clinical investigation or following the Ruan standard of subjective knowledge.
- Suntree Pharmacy: The DEA’s administrative revocation here was a mockery of due process. The agency excluded the testimony of the prescribing physicians and patients, relying instead on Dr. Gordon, a work-from-home hospice pharmacist. Dr. Gordon identified “red flags” as a proxy for illegitimacy without ever evaluating the medical necessity of the prescriptions in question.
- Miami-Luken (James Barclay): This wholesale distributor was used as a “scapegoat” after the DEA refused for years to provide guidance on what constituted “suspicious orders.” Following the Ruan decision, the government’s position became legally untenable, leading to a dismissal of the indictment. Tellingly, the government forced the defendants into an “unconditional release and hold harmless” agreement—a clear act of litigation damage control after realizing they could not prove subjective intent.
These cases reveal an agency that “quashes” valid court orders and “flip-flops” on policy to maintain its “omnipotent” power, regardless of the cost to healthcare providers or the patients they serve.

D.E.A. LAW ENFORCEMENT’S: “HOLY TRINITY”
Conclusion: Restoring the Boundary Between Law and Medicine
The fundamental distinction between a “Street Drug Dealer” and a “DEA-Registered Practitioner” is one of education, intent, and legal status. Doctors and pharmacists are accredited professionals who operate with an “intent to treat” within a regulated system. To characterize them as “drug dealers in white coats” is a perversion of the Controlled Substances Act that threatens the very fabric of American healthcare.
The jurisdictional boundary between law enforcement and medical practice must be aggressively restored. This brief demands immediate accountability:
6.Mandatory HHS Integration: Courts must reject any enforcement proceeding that does not include the binding scientific and medical evaluations of health agencies (HHS) as required by § 811(b).
7.Rejection of Junk Analytics: “Red flag” algorithms and insurance-driven analytics must be rejected as a substitute for individualized evidence of medical illegitimacy.
8.Strict Adherence to Ruan: The standard of subjective scienter must be applied to protect the good-faith professional judgment of practitioners from algorithmic persecution.

The DEA’s attempt to act as a national medical board is a jurisdictional usurpation that must be checked. The future of medicine depends on the ability of providers to exercise their professional judgment without the threat of law enforcement agencies manufacturing their own science to justify the destruction of medical careers.
The court must return the DEA to its authorized role: managing the flow of controlled substances, not the practice of medicine.
🔓 🔓 🔓
ALL WATCHED OVER BY MACHINES OF LOVING GRACE
HUNTED BY DOJ-DEA

BE SURE TO DONATE TO THE MARK IBSEN GOFUNDME DEFENSE FUND, WHERE THE SON ALWAYS RISES!!!

OUR TREE OF KNOWLEDGE SHALL NEVER BE SUPPRESSED



FOR NOW, YOU ARE WITHIN
THE NORMS
REFERENCES:

DR RICHARD “red” Lawhern
In the meantime, don’t forget: The National Campaign to Protect People in Pain will be bringing a new website online before the end of this week, in the domainhttps://www.ncp3.org . Like its predecessor, this site offers online resources for patients, their families, their doctors, and law firms that defend doctors from persecution by State Boards or law enforcement.
This site is not a competition with anything that others are doing. We are instead trying to build and promote a very “big tent” where every patient, doctor, and support group has an independent voice and can make that voice heard by Federal and State bureaucrats who are killing patients by denying them pain care.
